Anti-Cancer Effects of CKD-581, a Potent Histone Deacetylase Inhibitor against Diffuse Large B-Cell Lymphoma

Double-hit lymphoma (DHL) and double-expressor lymphoma (DEL) are aggressive forms of lymphoma that require better treatments to improve patient outcomes. CKD-581 is a new histone deacetylase (HDAC) inhibitor that exhibited a better safety profile in clinical trials compared to other HDAC inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo Jin, Kim, U Ji, Yoo, Hae Yong, Choi, Yong June, Kang, Keon Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352247/
https://www.ncbi.nlm.nih.gov/pubmed/32575557
http://dx.doi.org/10.3390/ijms21124377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352247/
https://www.ncbi.nlm.nih.gov/pubmed/32575557
http://dx.doi.org/10.3390/ijms21124377

Ejemplares similares